Phosphoinositide 3-kinase p110γ in immunity
✍ Scribed by Carlotta Costa; Erica L. Martin-Conte; Emilio Hirsch
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 161 KB
- Volume
- 63
- Category
- Article
- ISSN
- 1521-6543
- DOI
- 10.1002/iub.516
No coin nor oath required. For personal study only.
✦ Synopsis
The rapid and accurate response of leukocytes to environmental cues is critical for a proper inflammatory reaction to foreign particles or invading microbes. In the last decade, the signal transduction enzyme phosphoinositide 3-kinase c (PI3Kc) has emerged as a critical modulator of leukocyte responses, with its effects spanning from recruitment to the site of inflammation to the production of reactive oxygen species. These findings initially obtained from genetically modified mice have led to the development of experimental anti-inflammatory inhibitors with reasonable selectivity and specificity. While such molecules have not yet reached clinical use, preclinical studies combining genetics and pharmacology continue to provide new therapeutic indications for targeting PI3Kc. Thus, this review focuses on the latest discoveries regarding PI3Kc function in leukocytes and on the most recent findings in disease models related to immunity.
📜 SIMILAR VOLUMES
## Abstract Phosphoinositide 3‐kinases (PI3K) regulate immune activation __via__ their roles in signal transduction of multiple classes of receptors. Here, we examined the effect of genetic inactivation of the hemopoietic cell‐restricted PI3K isoform p110δ on systemic cytokine and chemokine respons
We have previously shown that CD4 ligands inhibit interleukin-2 (IL-2) production and T cell proliferation in human peripheral CD4 + T lymphocytes, in an MHC-independent way. Two major pathways implicated in T cell activation are inhibited by binding of CD4 ligands to the CD4 molecule, i. e. Ca 2+ s
## Abstract The modulation of L‐type calcium current (I~Ca,L~) is mainly due to mediators acting through activation of G protein‐coupled receptors (GPCR) and different protein kinases; among them, phosphoinositide 3‐kinaseγ (PI3Kγ) has been recently discovered to play an important role in the regul